Page last updated: 2024-12-08
uvinul t 150
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Uvinul T 150: RN given refers to cpd with unknown MF; no further information available 5/89 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 159201 |
| CHEMBL ID | 4462531 |
| SCHEMBL ID | 62195 |
| MeSH ID | M0164889 |
Synonyms (51)
| Synonym |
|---|
| octyl triazone |
| 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate |
| NCGC00183599-01 |
| 88122-99-0 |
| unii-xqn8r9sak4 |
| uvinul t 150 |
| uvasorb et |
| xqn8r9sak4 , |
| ec 402-070-1 |
| ethylhexyl triazone , |
| uvinul t150 |
| benzoic acid, 4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tris-, tris(2-ethylhexyl) ester |
| tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate |
| uvinul-t-150 |
| 116244-12-3 |
| FT-0688084 |
| octyl triazone [who-dd] |
| ethylhexyl triazone [inci] |
| 2,4,6-trianilino-(p-carbo-2'-ethylhexyl-1'-oxy)-1,3,5-triazine |
| ethylhexyl triazone [mi] |
| octil triazone |
| ethylhexyl triazone [usp-rs] |
| SCHEMBL62195 |
| Q-201502 |
| tris(2-ethylhexyl) 4,4',4''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl))tribenzoate |
| c48h66n6o6 |
| ethylhexyl triazone, analytical standard |
| ethylhexyl triazone, united states pharmacopeia (usp) reference standard |
| AKOS030228640 |
| CHEMBL4462531 |
| JGUMTYWKIBJSTN-UHFFFAOYSA-N |
| uvt-150 |
| 2,4,6-trianilino-p-(carbo-2'-ethylhexyl-1'-oxy)-1,3,5-triazine |
| DS-3287 |
| DTXSID90868994 |
| DB15469 |
| Q2455834 |
| HY-109655 |
| CS-0033785 |
| tris(2-ethylhexyl) 4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)trisbenzoate |
| E1312 |
| 4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)trisbenzoic acid tris(2-ethylhexyl) ester |
| uvt-150; uvinul t 150 pound>>ethylhexyl triazone pound>>uv-t-150 |
| BCP11409 |
| mfcd09753106 |
| AMY42004 |
| T73032 |
| benzoic acid, 4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tris-,1,1',1''-tris(2-ethylhexyl) ester |
| tris(2-ethylhexyl)4,4',4''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl))tribenzoate |
| SY077954 |
| tris(2-ethylhexyl) 4,4 inverted exclamation mark ,4 inverted exclamation mark inverted exclamation mark -[(1,3,5-triazine-2,4,6-triyl)tris(azanediyl)]tribenzoate |
Research Excerpts
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (9)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1611502 | Antioxidant activity assessed as DPPH free radical scavenging activity at 200 uM incubated for 60 mins by spectrophotometric method relative to control | 2019 | Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24 | Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer. |
| AID1611507 | Photoprotection activity against UV radiation | 2019 | Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24 | Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer. |
| AID1611506 | Thermal stability of compound in DMSO/methanol assessed as mass loss by UV spectroscopic method | 2019 | Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24 | Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer. |
| AID1611505 | Thermal stability of compound in DMSO/methanol assessed as decomposition temperature by UV spectroscopic method | 2019 | Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24 | Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer. |
| AID1611501 | Antioxidant activity assessed as DPPH free radical scavenging activity at 300 uM incubated for 60 mins by spectrophotometric method relative to control | 2019 | Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24 | Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer. |
| AID1611503 | Antioxidant activity assessed as DPPH free radical scavenging activity at 100 uM incubated for 60 mins by spectrophotometric method relative to control | 2019 | Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24 | Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer. |
| AID1611504 | Thermal stability of compound in DMSO/methanol assessed as onset temperature by UV spectroscopic method | 2019 | Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24 | Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer. |
| AID1611499 | Photoprotection activity against UV radiation assessed as ratio of UVA to UVB | 2019 | Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24 | Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer. |
| AID1611500 | Antioxidant activity assessed as DPPH free radical scavenging activity at 400 uM incubated for 60 mins by spectrophotometric method relative to control | 2019 | Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24 | Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (12)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 46.95
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (46.95) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 1 (8.33%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 11 (91.67%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||